[Successful treatment with imatinib for a patient with myeloid neoplasms with eosinophilia and abnormalities of PDGFRB due to t (5;14)(q33;q22)].

Eosinophilia / drug therapy Humans Imatinib Mesylate / therapeutic use Male Middle Aged Myeloproliferative Disorders / drug therapy Neoplasms Receptor, Platelet-Derived Growth Factor beta / genetics
Imatinib Platelet-derived growth factor receptor β t(5;14)(q33;q22)

Journal

[Rinsho ketsueki] The Japanese journal of clinical hematology
ISSN: 0485-1439
Titre abrégé: Rinsho Ketsueki
Pays: Japan
ID NLM: 2984782R

Informations de publication

Date de publication:
2021
Historique:
entrez: 6 12 2021
pubmed: 7 12 2021
medline: 15 12 2021
Statut: ppublish

Résumé

A 50-year old man with a 1-year history of eosinophilia presented with an eosinophil count exceeding 13,800/mm

Identifiants

DOI: 10.11406/rinketsu.62.1635 PMID: 34866089
pubmed: 34866089
doi: 10.11406/rinketsu.62.1635
doi:

Substances chimiques

Imatinib Mesylate 8A1O1M485B
PDGFRB protein, human EC 2.7.10.1
Receptor, Platelet-Derived Growth Factor beta EC 2.7.10.1

Types de publication

Case Reports Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

1635-1638

Auteurs

Tomoki Fujii (T)

Department of Hematology, Kantoh Rosai Hospital.
Department of Oncology, Kantoh Rosai Hospital.

Nobuhiro Ohno (N)

Department of Hematology, Kantoh Rosai Hospital.

Tomoharu Matsui (T)

Department of Hematology, Kantoh Rosai Hospital.
Department of Oncology, Kantoh Rosai Hospital.

Shinsuke Kitahara (S)

Department of Hematology, Kantoh Rosai Hospital.
Department of Oncology, Kantoh Rosai Hospital.

Seiichiro Kobayashi (S)

Department of Hematology, Kantoh Rosai Hospital.

Naohi Sahara (N)

Department of Hematology, Kantoh Rosai Hospital.

Nami Sakamoto (N)

Department of Hematology, Kantoh Rosai Hospital.

Takashi Matsunaga (T)

Department of Hematology, Kantoh Rosai Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Hémopathies et maladies lymphatiques › Hémopathies › Troubles leucocytaires › Éosinophilie › [Successful treatment with imatinib for a...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › [Successful treatment with imatinib for a...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Pyrimidines › Mésilate d'imatinib › [Successful treatment with imatinib for a...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › [Successful treatment with imatinib for a...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Hémopathies › Maladies de la moelle osseuse › Syndromes myéloprolifératifs › [Successful treatment with imatinib for a...
questionsmedicales.fr › Tumeurs › [Successful treatment with imatinib for a...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur facteur croissance › Récepteurs aux facteurs de croissance dérivés des plaquettes › Récepteur au PDGF bêta › [Successful treatment with imatinib for a...